LABD

Direxion Daily S&P Biotech Bear 3X Shares

$26.79

+0.00%

Market closed. Last update: 11:54 AM ET

📎 Investment Objective

The Direxion Daily S&P Biotech Bear 3X Shares (LABD) seeks to provide daily investment results that correspond to three times the inverse (-3x) of the daily performance of the S&P Biotechnology Select Industry Index.

Overview

ETF tracking Direxion Daily S&P Biotech Bear 3X Shares

Category Leveraged

Issuer Other

Inception Date 2015-05-28

Market Cap N/A

Average Volume N/A

Dividend Yield 0.91%

52-Week Range $26.79 - $140.60

VWAP $26.70

Performance

Loading performance data...

Price Chart

Investment Summary

📎 Investment Objective

🎯 Investment Strategy

LABD uses a combination of financial instruments, such as futures contracts and swap agreements, to provide the desired leveraged inverse exposure to the S&P Biotechnology Select Industry Index. The fund rebalances its portfolio on a daily basis to maintain the target -3x leverage.

✨ Key Features

Provides -3x daily leveraged exposure to the S&P Biotechnology Select Industry Index
Designed for short-term, tactical trading rather than long-term buy-and-hold investing
Employs derivatives to achieve its leveraged inverse exposure
Rebalances its portfolio daily to maintain the target leverage

⚠️ Primary Risks

Significant risk of loss due to the leveraged nature of the fund
Potential for large and sudden losses, especially in volatile markets
Compounding effect can magnify losses over longer holding periods
Tracking error risk due to the daily rebalancing and use of derivatives

👤 Best For

LABD is designed for experienced, risk-tolerant investors who seek short-term, speculative exposure to the biotechnology sector and understand the risks associated with leveraged and inverse ETFs. It is not suitable for long-term buy-and-hold investors or those with a low risk tolerance.